scispace - formally typeset
M

Mark Hartel

Researcher at Heidelberg University

Publications -  37
Citations -  2170

Mark Hartel is an academic researcher from Heidelberg University. The author has contributed to research in topics: Pancreatic cancer & Pancreatitis. The author has an hindex of 22, co-authored 35 publications receiving 2024 citations. Previous affiliations of Mark Hartel include Technische Universität München.

Papers
More filters
Journal ArticleDOI

High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas.

TL;DR: In pancreatic adenocarcinoma, the VEGF expression and the height of MVD are closely correlated, and both—rather than UICC stage and TNM classification—are markers of prognostic relevance after curative resection.
Journal ArticleDOI

Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas.

TL;DR: TFRC represents a marker of malignant transformation in the pancreas that could be applied as potential diagnostic and therapeutic target in solid tumours expressing this antigen.
Journal ArticleDOI

Expression and localization of human multidrug resistance protein (ABCC) family members in pancreatic carcinoma

TL;DR: In this paper, the authors quantified the mRNA expression of BCRP and all the members of the MRP family in normal human pancreas and pancreatic carcinoma and analyzed the mRNA level of the transporters most abundantly expressed in pancreatic tissue, including MRP, MDR1 P-glycoprotein (ABCB1), MRP3, MRP4 and MRP5, in 37 tissue samples.
Journal ArticleDOI

Vascular resection in pancreatic cancer surgery: survival determinants.

TL;DR: Resection of the superior mesenteric or portal vein to achieve macroscopic tumor clearance can be performed safely with acceptable operative morbidity and mortality, however, improved local clearance in these patients cannot achieve a favorable long-term survival for all patients.
Journal ArticleDOI

Renal cancer cell metastasis into the pancreas: a single-center experience and overview of the literature.

TL;DR: The results show that pancreatic resections for metastasis can be performed safely with a low rate of complications, and patients with a history of RCC should undergo a long-term follow-up to detect and evaluate for pancreatic metastases as well for metastases to other organ sites.